Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxapine for Restlessness During Mechanical Ventilation Weaning
NCT01193816Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2011
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of loxapine in Restlessness, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Weaning period at 28 days. Started May 2011; status: completed.
02
Drugs
loxapine
03
Conditions
Restlessness
Beyond the preview
Go deeper on NCT01193816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193816.